| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8652358 | The Annals of Thoracic Surgery | 2018 | 27 Pages |
Abstract
Enoxaparin 40 mg once daily is inadequate for most inpatients undergoing thoracic surgical procedures, based on a pharmacodynamic study of aFXa levels. Future research should examine the impact of weight-based once daily enoxaparin dosing versus twice daily enoxaparin dosing on prophylaxis adequacy.
Related Topics
Health Sciences
Medicine and Dentistry
Cardiology and Cardiovascular Medicine
Authors
Christopher J. MD, MS, Kory I. MPH, Kathleen MD, Lauren MPH PA-C, Ann Marie PharmD, BCPS, Thomas K. MD, MS,